| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 3.17e-05 | 149 | 49 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 7.00e-05 | 90 | 49 | 4 | GO:0030971 | |
| GeneOntologyMolecularFunction | kinase binding | GP6 PTPN1 MLXIPL TRADD RBBP6 PIK3R1 RHOBTB2 PTPN23 PPP1R9B CBL | 1.01e-04 | 969 | 49 | 10 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | 2.38e-04 | 873 | 49 | 9 | GO:0019901 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 5.27e-04 | 14 | 49 | 2 | GO:0036312 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase adaptor activity | 8.80e-04 | 18 | 49 | 2 | GO:0005068 | |
| GeneOntologyMolecularFunction | collagen binding | 1.04e-03 | 81 | 49 | 3 | GO:0005518 | |
| HumanPheno | Bruising susceptibility | 4.34e-06 | 178 | 21 | 7 | HP:0000978 | |
| HumanPheno | Subcutaneous hemorrhage | 4.45e-06 | 258 | 21 | 8 | HP:0001933 | |
| MousePheno | abnormal tooth morphology | 3.41e-05 | 318 | 41 | 7 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 3.48e-05 | 319 | 41 | 7 | MP:0030254 | |
| Domain | ssDNA-bd_transcriptional_reg | 1.86e-05 | 3 | 47 | 2 | IPR009044 | |
| Domain | CTF/NFI_DNA-bd_N | 3.71e-05 | 4 | 47 | 2 | IPR019548 | |
| Domain | NfI_DNAbd_pre-N | 3.71e-05 | 4 | 47 | 2 | PF10524 | |
| Domain | CTF_NFI | 3.71e-05 | 4 | 47 | 2 | PF00859 | |
| Domain | CTF/NFI_DNA-bd_CS | 3.71e-05 | 4 | 47 | 2 | IPR019739 | |
| Domain | CTF_NFI_1 | 3.71e-05 | 4 | 47 | 2 | PS00349 | |
| Domain | CTF/NFI_DNA-bd-dom | 3.71e-05 | 4 | 47 | 2 | IPR020604 | |
| Domain | CTF/NFI | 3.71e-05 | 4 | 47 | 2 | IPR000647 | |
| Domain | CTF_NFI_2 | 3.71e-05 | 4 | 47 | 2 | PS51080 | |
| Domain | SH2 | 1.73e-04 | 111 | 47 | 4 | PS50001 | |
| Domain | SH2 | 1.79e-04 | 112 | 47 | 4 | IPR000980 | |
| Domain | - | 1.79e-04 | 112 | 47 | 4 | 3.30.505.10 | |
| Domain | MAD_homology1_Dwarfin-type | 4.03e-04 | 12 | 47 | 2 | IPR003619 | |
| Domain | DWA | 4.03e-04 | 12 | 47 | 2 | SM00523 | |
| Domain | MH1 | 4.03e-04 | 12 | 47 | 2 | PF03165 | |
| Domain | SH2 | 2.09e-03 | 101 | 47 | 3 | PF00017 | |
| Domain | SH2 | 2.67e-03 | 110 | 47 | 3 | SM00252 | |
| Domain | PTPc | 3.70e-03 | 36 | 47 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 4.33e-03 | 39 | 47 | 2 | PS50055 | |
| Domain | PTPase_domain | 4.77e-03 | 41 | 47 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 4.77e-03 | 41 | 47 | 2 | PF00102 | |
| Domain | BTB | 7.59e-03 | 160 | 47 | 3 | PS50097 | |
| Domain | PTPc_motif | 9.68e-03 | 59 | 47 | 2 | SM00404 | |
| Domain | Tyr_Pase_cat | 9.68e-03 | 59 | 47 | 2 | IPR003595 | |
| Domain | BTB | 1.05e-02 | 180 | 47 | 3 | SM00225 | |
| Domain | RhoGAP | 1.06e-02 | 62 | 47 | 2 | SM00324 | |
| Domain | RhoGAP | 1.10e-02 | 63 | 47 | 2 | PF00620 | |
| Domain | BTB/POZ_dom | 1.13e-02 | 185 | 47 | 3 | IPR000210 | |
| Domain | RHOGAP | 1.13e-02 | 64 | 47 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 1.13e-02 | 64 | 47 | 2 | IPR000198 | |
| Domain | - | 1.13e-02 | 64 | 47 | 2 | 1.10.555.10 | |
| Domain | SKP1/BTB/POZ | 1.19e-02 | 189 | 47 | 3 | IPR011333 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 6.55e-05 | 36 | 31 | 3 | MM1418 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 7.11e-05 | 37 | 31 | 3 | M8615 | |
| Pathway | PID_ERBB1_INTERNALIZATION_PATHWAY | 9.70e-05 | 41 | 31 | 3 | M214 | |
| Pathway | PID_INSULIN_PATHWAY | 1.20e-04 | 44 | 31 | 3 | M16 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 1.87e-04 | 51 | 31 | 3 | M7955 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 1.90e-04 | 132 | 31 | 4 | M39338 | |
| Pathway | REACTOME_REGULATION_BY_C_FLIP | 2.54e-04 | 11 | 31 | 2 | M27249 | |
| Pathway | REACTOME_REGULATION_BY_C_FLIP | 3.60e-04 | 13 | 31 | 2 | MM14947 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 4.19e-04 | 14 | 31 | 2 | M16884 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 4.19e-04 | 14 | 31 | 2 | MM1485 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.19e-04 | 67 | 31 | 3 | MM15345 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 4.83e-04 | 15 | 31 | 2 | M29701 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 5.51e-04 | 16 | 31 | 2 | M26947 | |
| Pathway | WP_PROLACTIN_SIGNALING | 6.07e-04 | 76 | 31 | 3 | M39601 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 6.07e-04 | 76 | 31 | 3 | MM15442 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.80e-04 | 79 | 31 | 3 | M27643 | |
| Pathway | PID_MET_PATHWAY | 6.80e-04 | 79 | 31 | 3 | M48 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 7.01e-04 | 18 | 31 | 2 | M10145 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 7.01e-04 | 18 | 31 | 2 | MM1461 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 7.58e-04 | 82 | 31 | 3 | M1021 | |
| Pathway | PID_EPHA2_FWD_PATHWAY | 7.82e-04 | 19 | 31 | 2 | M273 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 7.82e-04 | 19 | 31 | 2 | M559 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 7.82e-04 | 19 | 31 | 2 | MM14555 | |
| Pathway | WP_APOPTOSIS | 7.85e-04 | 83 | 31 | 3 | MM15972 | |
| Pathway | KEGG_APOPTOSIS | 9.01e-04 | 87 | 31 | 3 | M8492 | |
| Pathway | WP_APOPTOSIS | 9.31e-04 | 88 | 31 | 3 | M39654 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 9.58e-04 | 21 | 31 | 2 | MM15347 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 9.58e-04 | 21 | 31 | 2 | M27645 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 9.58e-04 | 21 | 31 | 2 | MM15633 | |
| Pathway | WP_TCELL_RECEPTOR_SIGNALING | 9.94e-04 | 90 | 31 | 3 | M39725 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 1.05e-03 | 22 | 31 | 2 | M15258 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 1.05e-03 | 22 | 31 | 2 | M903 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION | 1.15e-03 | 23 | 31 | 2 | M1024 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 1.15e-03 | 23 | 31 | 2 | MM15176 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | 1.36e-03 | 25 | 31 | 2 | M563 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 1.47e-03 | 26 | 31 | 2 | MM1345 | |
| Pathway | PID_VEGFR1_PATHWAY | 1.47e-03 | 26 | 31 | 2 | M226 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 1.47e-03 | 26 | 31 | 2 | M27434 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 1.71e-03 | 28 | 31 | 2 | M41724 | |
| Pathway | PID_TRAIL_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M79 | |
| Pathway | PID_REELIN_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M69 | |
| Pathway | PID_IGF1_PATHWAY | 1.83e-03 | 29 | 31 | 2 | M125 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.83e-03 | 29 | 31 | 2 | MM15652 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 1.96e-03 | 30 | 31 | 2 | M234 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 1.96e-03 | 30 | 31 | 2 | M506 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 2.09e-03 | 31 | 31 | 2 | MM15467 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 2.09e-03 | 31 | 31 | 2 | M46423 | |
| Pathway | WP_4P163_COPY_NUMBER_VARIATION | 2.23e-03 | 32 | 31 | 2 | M48083 | |
| Pathway | REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS | 2.23e-03 | 32 | 31 | 2 | M29666 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 2.30e-03 | 431 | 31 | 5 | M39729 | |
| Pathway | PID_EPO_PATHWAY | 2.37e-03 | 33 | 31 | 2 | M233 | |
| Pathway | PID_NCADHERIN_PATHWAY | 2.37e-03 | 33 | 31 | 2 | M266 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.49e-03 | 439 | 31 | 5 | MM15595 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 2.66e-03 | 35 | 31 | 2 | M127 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 2.66e-03 | 35 | 31 | 2 | M41738 | |
| Pathway | REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS | 2.66e-03 | 35 | 31 | 2 | MM15168 | |
| Pathway | PID_HIV_NEF_PATHWAY | 2.66e-03 | 35 | 31 | 2 | M197 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 2.66e-03 | 35 | 31 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 2.66e-03 | 35 | 31 | 2 | M773 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.77e-03 | 450 | 31 | 5 | M27078 | |
| Pathway | PID_PDGFRB_PATHWAY | 2.79e-03 | 129 | 31 | 3 | M186 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.97e-03 | 37 | 31 | 2 | MM14564 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 2.97e-03 | 37 | 31 | 2 | MM15683 | |
| Pathway | PID_FAS_PATHWAY | 3.13e-03 | 38 | 31 | 2 | M94 | |
| Pathway | REACTOME_FLT3_SIGNALING | 3.13e-03 | 38 | 31 | 2 | M29803 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 3.24e-03 | 136 | 31 | 3 | M42547 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 3.30e-03 | 39 | 31 | 2 | MM15257 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 3.31e-03 | 137 | 31 | 3 | M18155 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 3.47e-03 | 40 | 31 | 2 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 3.47e-03 | 40 | 31 | 2 | MM15258 | |
| Pathway | PID_IFNG_PATHWAY | 3.47e-03 | 40 | 31 | 2 | M161 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 3.47e-03 | 40 | 31 | 2 | M62 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 3.64e-03 | 41 | 31 | 2 | M27533 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 3.64e-03 | 41 | 31 | 2 | MM15162 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION | 3.64e-03 | 41 | 31 | 2 | M739 | |
| Pathway | WP_IL2_SIGNALING | 3.81e-03 | 42 | 31 | 2 | M39536 | |
| Pathway | PID_TCPTP_PATHWAY | 3.81e-03 | 42 | 31 | 2 | M91 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 4.00e-03 | 43 | 31 | 2 | MM15864 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 4.00e-03 | 43 | 31 | 2 | M508 | |
| Pathway | PID_NFAT_TFPATHWAY | 4.37e-03 | 45 | 31 | 2 | M60 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8941725 | ||
| Pubmed | c-Cbl negatively regulates platelet activation by glycoprotein VI. | 1.87e-06 | 2 | 48 | 2 | 14629478 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8695807 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 10620516 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27884787 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 9414268 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8702998 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8995243 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8612729 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 10918571 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8896416 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20133944 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 9890943 | ||
| Pubmed | 4.47e-06 | 486 | 48 | 7 | 20936779 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19861161 | ||
| Pubmed | Interactions of Cbl with Grb2 and phosphatidylinositol 3'-kinase in activated Jurkat cells. | 5.59e-06 | 3 | 48 | 2 | 7791764 | |
| Pubmed | Role of Cbl in shear-activation of PI 3-kinase and JNK in endothelial cells. | 5.59e-06 | 3 | 48 | 2 | 11944898 | |
| Pubmed | Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis. | 5.59e-06 | 3 | 48 | 2 | 16798838 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 11030146 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 15581361 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 9099724 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 9160881 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 11087752 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 9259313 | ||
| Pubmed | c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology. | 5.59e-06 | 3 | 48 | 2 | 10633073 | |
| Pubmed | SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1. | 1.12e-05 | 4 | 48 | 2 | 34425214 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 17237826 | ||
| Pubmed | Nuclear factor one transcription factors as epigenetic regulators in cancer. | 1.12e-05 | 4 | 48 | 2 | 28076901 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 10940298 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 8947469 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9988765 | ||
| Pubmed | Transcription factor NF 1 expression in involuting mammary gland. | 1.12e-05 | 4 | 48 | 2 | 10959417 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 10358153 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 7590749 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 10391678 | ||
| Pubmed | RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin. | 1.12e-05 | 4 | 48 | 2 | 12624117 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9541596 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 11042121 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9052991 | ||
| Pubmed | Targeting of MIST to Src-family kinases via SKAP55-SLAP-130 adaptor complex in mast cells. | 1.12e-05 | 4 | 48 | 2 | 12681493 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9056636 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 12568726 | ||
| Pubmed | 1.28e-05 | 103 | 48 | 4 | 21706016 | ||
| Pubmed | A type III effector antagonizes death receptor signalling during bacterial gut infection. | 1.86e-05 | 5 | 48 | 2 | 24025841 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 8681376 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 18374639 | ||
| Pubmed | Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells. | 1.86e-05 | 5 | 48 | 2 | 15039234 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 7544353 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 9174058 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 24470255 | ||
| Pubmed | Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. | 1.86e-05 | 5 | 48 | 2 | 18449947 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 7642581 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 9223670 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 10799548 | ||
| Pubmed | Involvement of Src-homology-2-domain-containing protein-tyrosine phosphatase 2 in T cell activation. | 1.86e-05 | 5 | 48 | 2 | 8647120 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 9013636 | ||
| Pubmed | Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis. | 1.86e-05 | 5 | 48 | 2 | 24113870 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 19706729 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 9918857 | ||
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 2.09e-05 | 410 | 48 | 6 | 25814554 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.73e-05 | 430 | 48 | 6 | 35044719 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 11406619 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 11418612 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 17420256 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 10086340 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 9130710 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 9234717 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 16219545 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 10025673 | ||
| Pubmed | p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function. | 2.79e-05 | 6 | 48 | 2 | 19190244 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 9115297 | ||
| Pubmed | Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl. | 2.79e-05 | 6 | 48 | 2 | 15556646 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 9461587 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 15581362 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 9890970 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 23439647 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 21270437 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 9233773 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 11994282 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 9092538 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 12637493 | ||
| Pubmed | CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. | 3.90e-05 | 7 | 48 | 2 | 33512474 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 10762365 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 25220407 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 10962563 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 9660791 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 10660596 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 11031258 | ||
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 4.62e-05 | 50 | 48 | 3 | 19807924 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 16289966 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 11071869 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 8810341 | ||
| Pubmed | The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. | 5.19e-05 | 8 | 48 | 2 | 11133830 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 18539136 | ||
| Pubmed | TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. | 6.67e-05 | 9 | 48 | 2 | 15107835 | |
| Pubmed | LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. | 6.67e-05 | 9 | 48 | 2 | 9489702 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 14644197 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 14530346 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 15536084 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 16982329 | ||
| Interaction | GRB2 interactions | DOCK5 PTPN1 MLXIPL SH2D4A ABI3BP SYNJ1 AEBP1 RBBP6 GGN PIK3R1 DTX1 PTPN23 HELZ ZBTB12 CLNK CBL FASLG C1orf94 | 1.34e-13 | 806 | 48 | 18 | int:GRB2 |
| Interaction | GRAP2 interactions | 1.68e-07 | 104 | 48 | 6 | int:GRAP2 | |
| Interaction | NUP85 interactions | 1.83e-06 | 156 | 48 | 6 | int:NUP85 | |
| Interaction | CRK interactions | 2.38e-06 | 370 | 48 | 8 | int:CRK | |
| Interaction | NCK2 interactions | 2.71e-06 | 262 | 48 | 7 | int:NCK2 | |
| Interaction | VASP interactions | 5.78e-06 | 294 | 48 | 7 | int:VASP | |
| Interaction | SORBS2 interactions | 6.56e-06 | 111 | 48 | 5 | int:SORBS2 | |
| Interaction | RBM47 interactions | 8.61e-06 | 204 | 48 | 6 | int:RBM47 | |
| Interaction | LCP2 interactions | 8.84e-06 | 55 | 48 | 4 | int:LCP2 | |
| Interaction | SH3KBP1 interactions | 9.06e-06 | 315 | 48 | 7 | int:SH3KBP1 | |
| Interaction | SYNM interactions | 1.09e-05 | 58 | 48 | 4 | int:SYNM | |
| Interaction | ACTN1 interactions | 1.51e-05 | 341 | 48 | 7 | int:ACTN1 | |
| Interaction | TMCC1 interactions | 2.81e-05 | 25 | 48 | 3 | int:TMCC1 | |
| Interaction | TLE3 interactions | 2.84e-05 | 376 | 48 | 7 | int:TLE3 | |
| Interaction | FYB1 interactions | 5.44e-05 | 31 | 48 | 3 | int:FYB1 | |
| Interaction | HSPA2 interactions | 7.66e-05 | 440 | 48 | 7 | int:HSPA2 | |
| Interaction | PIK3CA interactions | 8.28e-05 | 188 | 48 | 5 | int:PIK3CA | |
| Interaction | SMAP2 interactions | 8.49e-05 | 189 | 48 | 5 | int:SMAP2 | |
| Interaction | FBRS interactions | 1.01e-04 | 102 | 48 | 4 | int:FBRS | |
| Interaction | TMCC3 interactions | 1.09e-04 | 39 | 48 | 3 | int:TMCC3 | |
| Interaction | SORBS3 interactions | 1.16e-04 | 202 | 48 | 5 | int:SORBS3 | |
| Interaction | ZNF800 interactions | 1.18e-04 | 40 | 48 | 3 | int:ZNF800 | |
| Interaction | KIF4A interactions | 1.27e-04 | 108 | 48 | 4 | int:KIF4A | |
| Interaction | CAPZB interactions | PTPN1 RBBP6 PRRC2C RHOBTB2 PPP1R9B SIRT6 CBL FYB1 VIRMA RAVER1 | 1.50e-04 | 1049 | 48 | 10 | int:CAPZB |
| Interaction | CDKL5 interactions | 1.51e-04 | 113 | 48 | 4 | int:CDKL5 | |
| Interaction | RRBP1 interactions | 1.51e-04 | 341 | 48 | 6 | int:RRBP1 | |
| Interaction | CBLB interactions | 1.61e-04 | 115 | 48 | 4 | int:CBLB | |
| Interaction | PDE3B interactions | 1.61e-04 | 115 | 48 | 4 | int:PDE3B | |
| Interaction | LAT interactions | 1.72e-04 | 117 | 48 | 4 | int:LAT | |
| Interaction | CLTA interactions | 1.77e-04 | 351 | 48 | 6 | int:CLTA | |
| Interaction | SMARCC2 interactions | 1.83e-04 | 353 | 48 | 6 | int:SMARCC2 | |
| Interaction | PTK2B interactions | 1.84e-04 | 119 | 48 | 4 | int:PTK2B | |
| Interaction | ITPR2 interactions | 1.96e-04 | 121 | 48 | 4 | int:ITPR2 | |
| Interaction | KMT2E interactions | 2.16e-04 | 49 | 48 | 3 | int:KMT2E | |
| Interaction | FER interactions | 2.30e-04 | 50 | 48 | 3 | int:FER | |
| Interaction | EPOR interactions | 2.30e-04 | 50 | 48 | 3 | int:EPOR | |
| Interaction | BCAS1 interactions | 2.47e-04 | 10 | 48 | 2 | int:BCAS1 | |
| Interaction | ATP6V1B2 interactions | 2.49e-04 | 238 | 48 | 5 | int:ATP6V1B2 | |
| Interaction | YES1 interactions | 2.53e-04 | 375 | 48 | 6 | int:YES1 | |
| Interaction | LARP4B interactions | 2.59e-04 | 240 | 48 | 5 | int:LARP4B | |
| Interaction | BCR interactions | 2.80e-04 | 244 | 48 | 5 | int:BCR | |
| Interaction | FCGR2A interactions | 2.89e-04 | 54 | 48 | 3 | int:FCGR2A | |
| Interaction | H2AC11 interactions | 3.01e-04 | 248 | 48 | 5 | int:H2AC11 | |
| Interaction | GALNT10 interactions | 3.05e-04 | 55 | 48 | 3 | int:GALNT10 | |
| Interaction | SH3BP1 interactions | 3.05e-04 | 55 | 48 | 3 | int:SH3BP1 | |
| Interaction | EZR interactions | 3.13e-04 | 553 | 48 | 7 | int:EZR | |
| Interaction | SNX19 interactions | 3.22e-04 | 56 | 48 | 3 | int:SNX19 | |
| Interaction | BCAR1 interactions | 3.23e-04 | 556 | 48 | 7 | int:BCAR1 | |
| Interaction | RB1 interactions | 3.30e-04 | 394 | 48 | 6 | int:RB1 | |
| Interaction | ITPR1 interactions | 3.52e-04 | 141 | 48 | 4 | int:ITPR1 | |
| Interaction | ITSN1 interactions | 3.68e-04 | 259 | 48 | 5 | int:ITSN1 | |
| Interaction | SRGAP3 interactions | 3.75e-04 | 59 | 48 | 3 | int:SRGAP3 | |
| Interaction | IRS1 interactions | 3.91e-04 | 145 | 48 | 4 | int:IRS1 | |
| Interaction | PRKCQ interactions | 4.14e-04 | 61 | 48 | 3 | int:PRKCQ | |
| Interaction | PIK3R1 interactions | 4.18e-04 | 412 | 48 | 6 | int:PIK3R1 | |
| Interaction | UPF1 interactions | 4.21e-04 | 581 | 48 | 7 | int:UPF1 | |
| Interaction | SV2B interactions | 4.26e-04 | 13 | 48 | 2 | int:SV2B | |
| Interaction | ITK interactions | 4.35e-04 | 62 | 48 | 3 | int:ITK | |
| Interaction | ZDBF2 interactions | 4.35e-04 | 62 | 48 | 3 | int:ZDBF2 | |
| Interaction | AHCTF1 interactions | 4.45e-04 | 150 | 48 | 4 | int:AHCTF1 | |
| Interaction | SNX9 interactions | 4.45e-04 | 150 | 48 | 4 | int:SNX9 | |
| Interaction | SNX33 interactions | 4.77e-04 | 64 | 48 | 3 | int:SNX33 | |
| Interaction | MAP3K5 interactions | 4.79e-04 | 153 | 48 | 4 | int:MAP3K5 | |
| Interaction | ARID2 interactions | 4.79e-04 | 153 | 48 | 4 | int:ARID2 | |
| Interaction | SEC16A interactions | 4.99e-04 | 426 | 48 | 6 | int:SEC16A | |
| Interaction | POP1 interactions | 5.00e-04 | 277 | 48 | 5 | int:POP1 | |
| Interaction | EIF2AK3 interactions | 5.03e-04 | 155 | 48 | 4 | int:EIF2AK3 | |
| Interaction | RLF interactions | 5.22e-04 | 66 | 48 | 3 | int:RLF | |
| Interaction | ZC3HAV1 interactions | 5.42e-04 | 606 | 48 | 7 | int:ZC3HAV1 | |
| Interaction | GLUL interactions | 5.67e-04 | 160 | 48 | 4 | int:GLUL | |
| Interaction | ZBTB41 interactions | 5.72e-04 | 15 | 48 | 2 | int:ZBTB41 | |
| Interaction | SH3YL1 interactions | 5.72e-04 | 15 | 48 | 2 | int:SH3YL1 | |
| Interaction | LGALS3BP interactions | 5.78e-04 | 286 | 48 | 5 | int:LGALS3BP | |
| Interaction | SH3D19 interactions | 5.95e-04 | 69 | 48 | 3 | int:SH3D19 | |
| Interaction | ZHX2 interactions | 5.95e-04 | 69 | 48 | 3 | int:ZHX2 | |
| Interaction | CLMN interactions | 5.95e-04 | 69 | 48 | 3 | int:CLMN | |
| Interaction | DEFA5 interactions | 6.21e-04 | 70 | 48 | 3 | int:DEFA5 | |
| Interaction | SH3GL1 interactions | 6.22e-04 | 164 | 48 | 4 | int:SH3GL1 | |
| Interaction | TCOF1 interactions | 6.35e-04 | 292 | 48 | 5 | int:TCOF1 | |
| Interaction | JAK2 interactions | 6.37e-04 | 165 | 48 | 4 | int:JAK2 | |
| Interaction | RHOBTB2 interactions | 6.37e-04 | 165 | 48 | 4 | int:RHOBTB2 | |
| Interaction | GDA interactions | 6.74e-04 | 72 | 48 | 3 | int:GDA | |
| Interaction | ATXN1 interactions | 6.77e-04 | 1039 | 48 | 9 | int:ATXN1 | |
| Interaction | TUBB3 interactions | 6.88e-04 | 453 | 48 | 6 | int:TUBB3 | |
| Interaction | RTN3 interactions | 7.12e-04 | 170 | 48 | 4 | int:RTN3 | |
| Interaction | TACC1 interactions | 7.28e-04 | 171 | 48 | 4 | int:TACC1 | |
| Interaction | KIAA0232 interactions | 7.30e-04 | 74 | 48 | 3 | int:KIAA0232 | |
| Interaction | ADARB2 interactions | 7.38e-04 | 17 | 48 | 2 | int:ADARB2 | |
| Interaction | ZNF57 interactions | 7.38e-04 | 17 | 48 | 2 | int:ZNF57 | |
| Interaction | BCOR interactions | 7.39e-04 | 302 | 48 | 5 | int:BCOR | |
| Interaction | CSF1R interactions | 7.59e-04 | 75 | 48 | 3 | int:CSF1R | |
| Interaction | SP7 interactions | 7.61e-04 | 304 | 48 | 5 | int:SP7 | |
| Interaction | VCL interactions | 7.72e-04 | 305 | 48 | 5 | int:VCL | |
| Interaction | POU2F1 interactions | 7.94e-04 | 175 | 48 | 4 | int:POU2F1 | |
| Interaction | NUP133 interactions | 7.94e-04 | 175 | 48 | 4 | int:NUP133 | |
| Interaction | ARID1B interactions | 8.28e-04 | 177 | 48 | 4 | int:ARID1B | |
| Interaction | SOX3 interactions | 8.29e-04 | 18 | 48 | 2 | int:SOX3 | |
| Interaction | HNRNPK interactions | 8.36e-04 | 853 | 48 | 8 | int:HNRNPK | |
| Cytoband | 8p21.2 | 3.30e-04 | 25 | 49 | 2 | 8p21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 4.15e-04 | 135 | 49 | 3 | chr8p21 | |
| Cytoband | 17p12 | 1.27e-03 | 49 | 49 | 2 | 17p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.58e-03 | 797 | 49 | 5 | chr19p13 | |
| Cytoband | 19p13.3 | 2.10e-03 | 237 | 49 | 3 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p12 | 2.16e-03 | 64 | 49 | 2 | chr17p12 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.24e-04 | 18 | 27 | 2 | 812 | |
| GeneFamily | SH2 domain containing | 4.49e-04 | 101 | 27 | 3 | 741 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3 | 2.42e-05 | 395 | 47 | 7 | GSM476678_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 2.98e-05 | 408 | 47 | 7 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.81e-05 | 298 | 47 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 5.04e-05 | 791 | 47 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.28e-05 | 184 | 47 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.34e-05 | 797 | 47 | 9 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_200 | 1.02e-04 | 110 | 47 | 4 | gudmap_kidney_adult_RenalCapsule_k3_200 | |
| CoexpressionAtlas | e9.5_FaceMesenchy_top-relative-expression-ranked_500 | 1.44e-04 | 364 | 47 | 6 | Facebase_ST1_e9.5_FaceMesenchy_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.56e-04 | 369 | 47 | 6 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.58e-04 | 123 | 47 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | 1.63e-04 | 372 | 47 | 6 | GSM538288_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3 | 1.75e-04 | 377 | 47 | 6 | GSM476681_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 1.84e-04 | 240 | 47 | 5 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.93e-04 | 384 | 47 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.52e-04 | 139 | 47 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 2.52e-04 | 978 | 47 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 2.77e-04 | 778 | 47 | 8 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 3.26e-04 | 797 | 47 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 3.32e-04 | 799 | 47 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.51e-04 | 607 | 47 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.51e-04 | 276 | 47 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 3.76e-04 | 814 | 47 | 8 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 3.92e-04 | 819 | 47 | 8 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.27e-04 | 288 | 47 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 4.75e-04 | 843 | 47 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.17e-04 | 168 | 47 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 5.23e-04 | 71 | 47 | 3 | GSM605811_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.act.IEL, CD8a+ CD8b- TCRd+ Vg5- CD44hi, Small Intestine, avg-3 | 5.23e-04 | 71 | 47 | 3 | GSM605808_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.act.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44hi, Small Intestine, avg-3 | 5.67e-04 | 73 | 47 | 3 | GSM605802_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 5.90e-04 | 174 | 47 | 4 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.21e-04 | 878 | 47 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 6.38e-04 | 76 | 47 | 3 | GSM605805_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 6.63e-04 | 77 | 47 | 3 | GSM605894_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 6.88e-04 | 78 | 47 | 3 | GSM605891_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.67e-04 | 498 | 47 | 6 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.90e-04 | 330 | 47 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 9.78e-04 | 88 | 47 | 3 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_100 | 9.78e-04 | 88 | 47 | 3 | gudmap_kidney_adult_RenalCapsule_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.99e-04 | 524 | 47 | 6 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 1.04e-03 | 351 | 47 | 5 | GSM538325_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 1.05e-03 | 203 | 47 | 4 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 1.18e-03 | 94 | 47 | 3 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.22e-03 | 95 | 47 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | e10.5_MandibArch_top-relative-expression-ranked_500_4 | 1.28e-03 | 24 | 47 | 2 | Facebase_ST1_e10.5_MandibArch_500_4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_200 | 1.28e-03 | 24 | 47 | 2 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.33e-03 | 371 | 47 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 1.43e-03 | 770 | 47 | 7 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 1.55e-03 | 384 | 47 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | e10.5_ColumEpith_Mandib_top-relative-expression-ranked_500_4 | 1.56e-03 | 226 | 47 | 4 | Facebase_ST1_e10.5_ColumEpith_Mandib_500_4 | |
| CoexpressionAtlas | NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3 | 1.57e-03 | 385 | 47 | 5 | GSM538285_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 1.62e-03 | 388 | 47 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.65e-03 | 790 | 47 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 1.66e-03 | 390 | 47 | 5 | GSM538291_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.69e-03 | 231 | 47 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | DOCK5 MLXIPL IER5L DTX1 RHOBTB2 GLIS2 ARHGAP44 ZBTB12 KCTD17 | 1.69e-03 | 1275 | 47 | 9 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.75e-03 | 395 | 47 | 5 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.79e-03 | 801 | 47 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.57e-08 | 196 | 49 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 168 | 49 | 5 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-06 | 175 | 49 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.09e-06 | 190 | 49 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 192 | 49 | 5 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-06 | 192 | 49 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.20e-06 | 192 | 49 | 5 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 49 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 193 | 49 | 5 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 194 | 49 | 5 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.37e-06 | 195 | 49 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-06 | 195 | 49 | 5 | 773728703bc8969bff0e1de58fe3e1631add0a0a | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.37e-06 | 195 | 49 | 5 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.37e-06 | 195 | 49 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-06 | 196 | 49 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-06 | 198 | 49 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.56e-06 | 198 | 49 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.56e-06 | 198 | 49 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 198 | 49 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 198 | 49 | 5 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.62e-06 | 199 | 49 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 155 | 49 | 4 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 165 | 49 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 166 | 49 | 4 | 410843ad44f9b22d5476119ac0d7c9168e17ac4b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 167 | 49 | 4 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.57e-05 | 169 | 49 | 4 | 0ee74cc97a2db9cc16dc73424f74747afe13af90 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-05 | 170 | 49 | 4 | f9596088a1a7686467e54eabaad5269f2c5fbfec | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.73e-05 | 171 | 49 | 4 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 171 | 49 | 4 | f08402d0f42822c35673522043b652f8fb68d2f6 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-mature_NK_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.73e-05 | 171 | 49 | 4 | a0462781d22c391b3c6c8a72586c385ac089ca5d | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.73e-05 | 171 | 49 | 4 | 85b655dc8a3cbf0e8097e951116490e326a795ac | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 171 | 49 | 4 | f12c2e48637b96557afbc2006a3a23ba21b7951e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 171 | 49 | 4 | 12c98dea7370377695c5d22309f78ba03e282a0e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-05 | 177 | 49 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-05 | 177 | 49 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 178 | 49 | 4 | 08c6794eb21c062c7e6c2e297e8c14dcf0e12774 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 184 | 49 | 4 | 8095be57ed189763b5be039f330149a41e5b406a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 49 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 187 | 49 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 49 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-05 | 188 | 49 | 4 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | (0)_NK_CD160pos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.51e-05 | 189 | 49 | 4 | 713991025bb92d38cb0507ff01fd91b48c8af45a | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 5.51e-05 | 189 | 49 | 4 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 189 | 49 | 4 | 637f26503e4bd7b4e5642ec1a722ffabcda4fac7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-05 | 189 | 49 | 4 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 189 | 49 | 4 | 2424e4dc9e8c7f5b3b31272405c6c1d4c8af6d9e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 49 | 4 | 9a43d1e7e1291cb23db6466967ec70c41fc0880c | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.63e-05 | 190 | 49 | 4 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 190 | 49 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 190 | 49 | 4 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 190 | 49 | 4 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 190 | 49 | 4 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 49 | 4 | 805ce69e7e91a6a8f04e8ccbd4bfca4e804be43d | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 49 | 4 | 12931a56d18c6dc79bd21148255dace8115abf0c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 190 | 49 | 4 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-05 | 191 | 49 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | 783e8c436de90623bb1bc4117270d60c8c8a9461 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-05 | 191 | 49 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 6d4fe7ea278efa4b9d43f8a3c282bc0e0e9abaea | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 192 | 49 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 2c6406bc97c3224099b94a43f2890f057b528fa6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 192 | 49 | 4 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-05 | 192 | 49 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 192 | 49 | 4 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 47aed7c8e6f5ce1084821212a04f568319e65fd6 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 192 | 49 | 4 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 735a72fac16397edde95e8eefa6f83caeb5ee5df | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.98e-05 | 193 | 49 | 4 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 193 | 49 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.98e-05 | 193 | 49 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 193 | 49 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-05 | 193 | 49 | 4 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.98e-05 | 193 | 49 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | ff901d2f3d7a511639c1e3b76058896c0d8a8602 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-05 | 193 | 49 | 4 | f1f1097204e07a7bed416425b8256942038a734f | |
| Disease | platelet component distribution width | 2.06e-04 | 755 | 48 | 7 | EFO_0007984 | |
| Disease | reticulocyte count | 2.58e-04 | 1045 | 48 | 8 | EFO_0007986 | |
| Disease | Vitiligo | 3.47e-04 | 17 | 48 | 2 | C0042900 | |
| Disease | body surface area | 5.90e-04 | 643 | 48 | 6 | EFO_0022196 | |
| Disease | Vitiligo | 6.02e-04 | 101 | 48 | 3 | EFO_0004208 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.09e-03 | 30 | 48 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | joint hypermobility measurement | 1.32e-03 | 33 | 48 | 2 | EFO_0007905 | |
| Disease | diet measurement | 1.45e-03 | 1049 | 48 | 7 | EFO_0008111 | |
| Disease | multiple myeloma (is_marker_for) | 1.58e-03 | 36 | 48 | 2 | DOID:9538 (is_marker_for) | |
| Disease | neuroimaging measurement | 1.62e-03 | 1069 | 48 | 7 | EFO_0004346 | |
| Disease | telomere length | 1.67e-03 | 313 | 48 | 4 | EFO_0004505 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 2.24e-03 | 43 | 48 | 2 | EFO_0004471, EFO_0006896 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.73e-03 | 171 | 48 | 3 | DOID:9352 (is_implicated_in) | |
| Disease | autoimmune disease | 2.82e-03 | 173 | 48 | 3 | EFO_0005140 | |
| Disease | urate measurement | 3.17e-03 | 895 | 48 | 6 | EFO_0004531 | |
| Disease | skin aging measurement | 3.21e-03 | 181 | 48 | 3 | EFO_0008006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLLPQPPLPPMFPLR | 166 | Q99218 | |
| RIEPPVKPLLPPLPP | 286 | Q8IUX7 | |
| KLFPPPLSPLPEDPP | 911 | P51816 | |
| LLPPRPPPARPDKLP | 291 | Q6P1W5 | |
| PFPPPPPRTPLLWLL | 21 | Q96KC8 | |
| PLLPPPPPPANARLA | 26 | O95450 | |
| PELPPRRGKPPPLLP | 426 | Q8IY67 | |
| AEPPPPPKLPLPAFR | 606 | Q3YEC7 | |
| PPPRPTAPKPLLPRR | 716 | Q9H3S7 | |
| LRLPPKPPPPLQPLL | 186 | Q14296 | |
| IPPPPRPPKRILEPH | 306 | P18031 | |
| FLLPPPPPVARPVPL | 431 | Q14938 | |
| QPPPPPPPVRRKLAL | 21 | Q9Y662 | |
| QRPLPPLPPLPLTRK | 306 | Q9HCN6 | |
| FTLGPPPPKPNRPPN | 351 | O15117 | |
| PPSLRPLKPPPPPRQ | 136 | Q86UU5 | |
| QELLQLRPPPKPPLP | 326 | Q9BZE0 | |
| RQPAPALPPKPPKPT | 301 | P27986 | |
| SLAQPPLPVLPPFPP | 216 | P78563 | |
| PLPVLPPFPPPSGKN | 221 | P78563 | |
| HPLPQLPRPPFPIPQ | 1361 | P42694 | |
| PANLFSLPPLPPPPL | 251 | Q8N5Z5 | |
| SQRRKAPPAPPLPPP | 221 | Q86Y01 | |
| RLRKQLPPPPPPIPP | 331 | Q7Z6E9 | |
| RPKLPPSPNNPPKFP | 71 | Q8TAX7 | |
| LPVRREAKAPPPPPP | 1841 | Q9H7D0 | |
| VSPPPPLPHFRLPPL | 31 | Q9BQY9 | |
| PPPALPLPPAPALLA | 51 | Q96A19 | |
| KPLPVPPTLRDLPPP | 531 | P22681 | |
| RPPEKPPRPPRPLHL | 286 | Q5T9C2 | |
| PLPLPPPAPAALCPR | 186 | Q5T953 | |
| KPPPPPPPAQTFLFQ | 191 | Q15628 | |
| QPLEPKRPPPPRPVA | 1101 | O43426 | |
| VLRKPNPPPPPPRLT | 116 | Q569H4 | |
| RPLLQAPFLPPKPPP | 226 | Q9BYZ6 | |
| LPPPPKLLAQQHPPP | 406 | Q9Y520 | |
| LVPKPPPAKPSRPRP | 601 | Q9C0A6 | |
| PPGLPRLALPPATKP | 446 | P08651 | |
| LPPLPRPPTPKLEPK | 286 | Q8N6T7 | |
| FLLPEDPKPRLPPPP | 376 | Q9NP71 | |
| KPRQRPTLPPPQPPT | 731 | Q17R89 | |
| NKIPLPPPRPLITLP | 156 | Q7Z7G1 | |
| PLPPPLLRPVKLEFP | 171 | Q9Y330 | |
| PLRVPQKPERPPLPP | 276 | Q9H788 | |
| PPPPPEPRRPSIAFK | 121 | A0A286YF18 | |
| PPLPPLPLPPLKKRG | 61 | P48023 | |
| PLPPRPTHPRRKPLP | 701 | Q7Z7G0 | |
| PPPPQPQPSLKRNPK | 146 | Q69YN4 | |
| PPPPLAPVLLRKPSL | 196 | Q96HE9 | |
| PPKGRLPAPPPRDLL | 81 | Q13488 | |
| KRSRVFQPPPPPPPA | 246 | Q96SB3 |